ArticleFamilial cancer2018

Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.

Aleksander Myszka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.